We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PIPELINES COULD GET BOOST FROM PHARMA-BIOTECH COLLABORATION
PIPELINES COULD GET BOOST FROM PHARMA-BIOTECH COLLABORATION
February 24, 2004
The pharmaceutical industry’s interest in early-stage compounds for drugs in the pipeline may create new opportunities for biotechnology companies to supplement their research and development efforts, according to the participants in a panel discussion held at the BIO CEO & Investor Conference in New York City yesterday.